EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting the MCP‐GPX4/HMGB1 Axis for Effectively Triggering Immunogenic Ferroptosis in Pancreatic Ductal Adenocarcinoma

Ge Li iD, Chengyu Liao, Jiangzhi Chen, Zuwei Wang, Shuncang Zhu, Jianlin Lai, Qiaowei Li, Yinhao Chen, Dihan Wu, Jianbo Li, Yi Huang, Yifeng Tian und 2 weitere

Advanced Science · 2024-06 · 11 (21)

DOI: 10.1002/advs.202308208 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 09.04.2024. Verfasst von Ge Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery and Fujian Institute of Hepatobiliary Surgery, Fujian Medical University Union Hospital, Fuzhou, 350001, China. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Disease Models, Animal, Ferroptosis, HMGB1 Protein. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Major Scientific Research Project of Young and Middle-aged people of Fujian Provincial Health Commission, National Natural Science Foundation of China, Natural Science Foundation of Fujian Province of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Induction of ferroptosis can inhibit cancer cells in vitro, however, the role of ferroptosis in treatment in vivo is controversial. The immunosuppressive cells activated by the ferroptotic tumor cells can promote the growth of residual tumor cells, hindering the application of ferroptosis stimulation in tumor treatment. In this study, a new strategy is aimed to be identified for effectively triggering immunogenic ferroptosis in pancreatic ductal adenocarcinoma (PDAC) and simultaneously stimulating antitumor immune responses. Toward this, several molecular and biochemical experiments are performed using patient‐derived organoid models and a KPC mouse model ( LSL ‐ Kras G12D /+ , LSL‐Trp53 R172H/+ , Pdx‐1‐Cre ). It is observed that the inhibition of macrophage‐capping protein (MCP) suppressed the ubiquitin fold modifier (UFM)ylation of pirin (PIR), a newly identified substrate of UFM1, thereby decreasing the transcription of GPX4 , a marker of ferroptosis, and promoting the cytoplasmic transportation of HMGB1, a damage‐associated molecular pattern. GPX4 deficiency triggered ferroptosis, and the pre‐accumulated cytosolic HMGB1 is released rapidly. This altered release pattern of HMGB1 facilitated the pro‐inflammatory M1‐like polarization of macrophages. Thus, therapeutic inhibition of MCP yielded dual antitumor effects by stimulating ferroptosis and activating antitumor pro‐inflammatory M1‐like macrophages. The nanosystem developed for specifically silencing MCP is a promising tool for treating PDAC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalDisease Models, AnimalFerroptosisHMGB1 ProteinPancreatic NeoplasmsPhospholipid Hydroperoxide Glutathione PeroxidaseAnimalsHumansMiceMicrofilament ProteinsNuclear Proteins

Substanzen

HMGB1 ProteinPhospholipid Hydroperoxide Glutathione PeroxidaseGPX4 protein, humanCAPG protein, humanMicrofilament ProteinsNuclear Proteins

Autor:innen und Institutionen

  • Department of Hepatobiliary Surgery and Fujian Institute of Hepatobiliary Surgery, Fujian Medical University Union Hospital, Fuzhou, 350001, China.
  • Shengli Clinical Medical College of Fujian Medical University, Fujian Medical University, Fuzhou, 350001, China.
  • Department of Hepatopancreatobiliary Surgery, Fujian Provincial Hospital, Fuzhou, 350001, China.
  • Fujian Provincial Center for Geriatrics, Fuzhou, 350001, China.
  • Fujian Key Laboratory of Geriatrics, Fuzhou, 350001, China.
  • Center for Experimental Research in Clinical Medicine, Fujian Provincial Hospital, Fuzhou, 350001, China.

ORCID-Profile: Ge Li, Shi Chen

Förderung

  • Major Scientific Research Project of Young and Middle-aged people of Fujian Provincial Health Commission
  • National Natural Science Foundation of China
  • Natural Science Foundation of Fujian Province of China
  • Medical Innovation Project of Fujian Provincial Health Commission
  • Joint Funds for the innovation of science and Technology, Fujian province

Zitieren

APA

Li, G., Liao, C., Chen, J., Wang, Z., Zhu, S., Lai, J., Li, Q., Chen, Y., Wu, D., Li, J., Huang, Y., Tian, Y., Chen, Y., & Chen, S. (2024). Targeting the MCP‐GPX4/HMGB1 Axis for Effectively Triggering Immunogenic Ferroptosis in Pancreatic Ductal Adenocarcinoma. Advanced Science, 11(21). https://doi.org/10.1002/advs.202308208

Vancouver

Li G, Liao C, Chen J, Wang Z, Zhu S, Lai J, et al. Targeting the MCP‐GPX4/HMGB1 Axis for Effectively Triggering Immunogenic Ferroptosis in Pancreatic Ductal Adenocarcinoma. Advanced Science. 2024;11(21). doi:10.1002/advs.202308208

BibTeX
@article{Li2024,
  author = {Li, Ge and Liao, Chengyu and Chen, Jiangzhi and Wang, Zuwei and Zhu, Shuncang and Lai, Jianlin and Li, Qiaowei and Chen, Yinhao and Wu, Dihan and Li, Jianbo and Huang, Yi and Tian, Yifeng and Chen, Yanling and Chen, Shi},
  title = {Targeting the MCP‐GPX4/HMGB1 Axis for Effectively Triggering Immunogenic Ferroptosis in Pancreatic Ductal Adenocarcinoma},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {21},
  doi = {10.1002/advs.202308208}
}
Kostenlos starten →